Clinical Trials Directory

Trials / Unknown

UnknownNCT03717818

Mechanisms of Change in Brief Treatment for Borderline Personality Disorder

Mechanisms of Change in Brief Treatment for Borderline Personality Disorder: A Randomized Controlled Trial

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
80 (estimated)
Sponsor
University of Lausanne Hospitals · Academic / Other
Sex
All
Age
18 Years – 35 Years
Healthy volunteers
Not accepted

Summary

The present two-arm randomized controlled study aims at testing the effects (i.e., symptom reduction) and the underlying mechanisms of change associated with a brief psychiatric treatment (10 sessions over 4 months), compared with treatment as usual. Participants undergo assessments at four points (intake, 2 months, discharge and 12 month follow-up). In addition to symptom measures, all individuals undergo a two-step assessment for the potential mechanisms of change (i.e., emotion and socio-cognitive processing): a) behavioural and b) neurofunctional. We hypothesize that change in the mechanisms explains the treatment effects. The present study uses an innovative treatment of BPD and at the same time a sophisticated assessment procedure to demonstrate the critical role of psychobiological change in emotion and sociocognitive processing in brief treatments. It will help increase the effectiveness of initial treatment phase for BPD and help diminish the societal burden of disease related with BPD. This study is funded by the Swiss National Science Foundation (SNSF).

Conditions

Interventions

TypeNameDescription
BEHAVIORALGood Psychiatric Management - Briefspecific interventions as defined by Gunderson and Links (2014)
BEHAVIORALtreatment as usualnon-specific intervention

Timeline

Start date
2018-10-19
Primary completion
2022-12-01
Completion
2022-12-01
First posted
2018-10-24
Last updated
2018-10-25

Locations

1 site across 1 country: Switzerland

Source: ClinicalTrials.gov record NCT03717818. Inclusion in this directory is not an endorsement.